We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ALB ended 2025 with $3.2B liquidity with operating cash flow up 86% year over year.
Albemarle generated $692M free cash flow in 2025 and sees meaningful gains in 2026.
ALB's strong liquidity and surging cash flow add strength to its growth plans.
Albemarle Corporation (ALB - Free Report) ended fourth-quarter 2025 with robust liquidity of around $3.2 billion, including cash and cash equivalents of roughly $1.6 billion. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from 2025.
ALB generated free cash flow of $692 million for full-year 2025, driven by strong cash conversion, lower capital spending and productivity measures. ALB expects to generate meaningful free cash flow in 2026. Free cash flow is expected to be driven by the recent uptick in lithium prices, strong cash conversion and productivity.
The company’s strong liquidity and surging cash flow add strength to its growth plans and debt reduction efforts, while driving shareholder value. A robust balance sheet supports ALB’s major organic growth initiatives through investment in high-return projects and strategic resources. The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.
ALB recently completed the divestment of a controlling stake in its Ketjen Corporation’s refining catalyst solutions business to affiliates of KPS Capital Partners, LP. The transaction was followed by Albemarle’s divestment of its 50% interest in the Eurecat joint venture to Axens SA, completed in January 2026. The two deals combined generated $670 million in pre-tax proceeds, which are expected to be used for debt reduction and other general corporate purposes, enhancing its financial flexibility.
Among its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) exited 2025 with strong liquidity, cash and cash equivalents of around $1.75 billion. Sociedad Quimica’s solid cash position supports its capital investment in growth projects and shareholder-friendly actions. Sociedad Quimica expects total capital expenditure of $2.7 billion for the 2025–2027 period, which includes the expansion of lithium carbonate and lithium hydroxide capacity in Chile, the expansion of the Mt. Holland project and investments to develop the Andover project, both in Australia.
ICL Group Ltd. (ICL - Free Report) ended 2025 with cash and cash equivalents, and short-term investments and deposits of $496 million. ICL Group also had roughly $1.1 billion of unused credit facilities. ICL generated an operating cash flow of $1,056 million in 2025.
ALB’s Price Performance, Valuation & Estimates
Albemarle has gained 103.2% in the past six months compared with the Zacks Chemical - Diversified industry’s rise of 6.1%.
Image Source: Zacks Investment Research
ALB is currently trading at a forward price-to-sales ratio of 3.42, above the industry. It carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 1,131.7%. The EPS estimates for 2026 have been trending higher over the past 60 days.
View the Zacks #1 Rank List
Image: Bigstock
ALB's Strong Liquidity: Powering Organic Growth Investments Ahead?
Key Takeaways
Albemarle Corporation (ALB - Free Report) ended fourth-quarter 2025 with robust liquidity of around $3.2 billion, including cash and cash equivalents of roughly $1.6 billion. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from 2025.
ALB generated free cash flow of $692 million for full-year 2025, driven by strong cash conversion, lower capital spending and productivity measures. ALB expects to generate meaningful free cash flow in 2026. Free cash flow is expected to be driven by the recent uptick in lithium prices, strong cash conversion and productivity.
The company’s strong liquidity and surging cash flow add strength to its growth plans and debt reduction efforts, while driving shareholder value. A robust balance sheet supports ALB’s major organic growth initiatives through investment in high-return projects and strategic resources. The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.
ALB recently completed the divestment of a controlling stake in its Ketjen Corporation’s refining catalyst solutions business to affiliates of KPS Capital Partners, LP. The transaction was followed by Albemarle’s divestment of its 50% interest in the Eurecat joint venture to Axens SA, completed in January 2026. The two deals combined generated $670 million in pre-tax proceeds, which are expected to be used for debt reduction and other general corporate purposes, enhancing its financial flexibility.
Among its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) exited 2025 with strong liquidity, cash and cash equivalents of around $1.75 billion. Sociedad Quimica’s solid cash position supports its capital investment in growth projects and shareholder-friendly actions. Sociedad Quimica expects total capital expenditure of $2.7 billion for the 2025–2027 period, which includes the expansion of lithium carbonate and lithium hydroxide capacity in Chile, the expansion of the Mt. Holland project and investments to develop the Andover project, both in Australia.
ICL Group Ltd. (ICL - Free Report) ended 2025 with cash and cash equivalents, and short-term investments and deposits of $496 million. ICL Group also had roughly $1.1 billion of unused credit facilities. ICL generated an operating cash flow of $1,056 million in 2025.
ALB’s Price Performance, Valuation & Estimates
Albemarle has gained 103.2% in the past six months compared with the Zacks Chemical - Diversified industry’s rise of 6.1%.
ALB is currently trading at a forward price-to-sales ratio of 3.42, above the industry. It carries a Value Score of D.
The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 1,131.7%. The EPS estimates for 2026 have been trending higher over the past 60 days.
ALB currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.